These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8067244)

  • 1. Effects of a new administration form of oxymetazoline on maxillary ostial patency in healthy individuals and patients with acute rhinitis.
    Ackerhans M; Jannert M; Tönnesson M
    Acta Otolaryngol Suppl; 1994; 515():49-52. PubMed ID: 8067244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new administration form of the nasal decongestant oxymetazoline: a study on the change of ostial patency in healthy individuals.
    Jannert M; Fryksmark U; Ackerhans M; Nilson K
    Rhinology; 1994 Jun; 32(2):78-80. PubMed ID: 7939146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of oxymetazoline administered with a nasal bellows container and combined with oral phenoxymethyl-penicillin in the treatment of acute maxillary sinusitis.
    Wiklund L; Stierna P; Berglund R; Westrin KM; Tönnesson M
    Acta Otolaryngol Suppl; 1994; 515():57-64. PubMed ID: 8067245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxymetazoline nose drops on acute sinusitis in the rabbit.
    Bende M; Fukami M; Arfors KE; Mark J; Stierna P; Intaglietta M
    Ann Otol Rhinol Laryngol; 1996 Mar; 105(3):222-5. PubMed ID: 8615587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between ostial patency and medical treatment in acute maxillary sinusitis: an experimental study].
    Kutluhan A; Inalkaç E; Kiroğlu AF; Akpolat N; Kiriş M
    Kulak Burun Bogaz Ihtis Derg; 2002; 9(4):275-81. PubMed ID: 12422083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal corticosteroid and oxymetazoline for chronic rhinitis: a systematic review.
    Neighbors CL; Salvador CF; Zhu B; Camacho M; Tsai P
    J Laryngol Otol; 2022 Jan; 136(1):8-16. PubMed ID: 34702392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of the effect of oxymetazoline on the duration of rhinitis. results of a placebo-controlled double-blind study in patients with acute rhinitis].
    Reinecke S; Tschaikin M
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():113-8. PubMed ID: 16261947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers.
    Graf P; Hallén H; Juto JE
    Clin Exp Allergy; 1995 May; 25(5):395-400. PubMed ID: 7553241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of oxymetazoline plus intranasal steroid in the treatment of chronic rhinitis: A randomised controlled trial.
    Thongngarm T; Assanasen P; Pradubpongsa P; Tantilipikorn P
    Asian Pac J Allergy Immunol; 2016 Mar; 34(1):30-7. PubMed ID: 26994623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the nasal decongestant oxymetazoline on human olfactory and intranasal trigeminal function in acute rhinitis.
    Hummel T; Rothbauer C; Pauli E; Kobal G
    Eur J Clin Pharmacol; 1998 Sep; 54(7):521-8. PubMed ID: 9832293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity.
    Graf P; Hallén H; Juto JE
    Acta Otolaryngol; 1995 Jan; 115(1):71-5. PubMed ID: 7762389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers.
    Hallén H; Graf P
    Clin Exp Allergy; 1995 May; 25(5):401-5. PubMed ID: 7553242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis.
    Graf P; Enerdal J; Hallén H
    Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1128-32. PubMed ID: 10522506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
    Graf P; Hallén H
    Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anesthetic Efficacy of Intranasal 3% Tetracaine plus 0.05% Oxymetazoline (Kovanaze) in Maxillary Teeth.
    Capetillo J; Drum M; Reader A; Fowler S; Nusstein J; Beck M
    J Endod; 2019 Mar; 45(3):257-262. PubMed ID: 30803532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
    Druce HM; Ramsey DL; Karnati S; Carr AN
    Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Nasal Esketamine in Patients with Allergic Rhinitis with and Without Nasal Decongestant Pretreatment and in Healthy Subjects with and Without Nasal Corticosteroid Pretreatment.
    Zannikos P; Solanki B; De Meulder M; Badorrek P; Hohlfeld JM; Singh J
    Clin Pharmacokinet; 2023 Sep; 62(9):1315-1328. PubMed ID: 37402024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
    Baroody FM; Brown D; Gavanescu L; DeTineo M; Naclerio RM
    J Allergy Clin Immunol; 2011 Apr; 127(4):927-34. PubMed ID: 21377716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.